Regulatory 2020-03-31 | Change in number of shares and votes in Ascelia Pharma AB PDF Report Presentation Webcast
2020-03-05 | Analysguiden/Carlsquare updates its view on Ascelia Pharma and raises target share price PDF Report Presentation Webcast
Regulatory 2020-03-02 | Issue and repurchase of series C shares for share saving program PDF Report Presentation Webcast
2020-02-20 | Vator Securities: Ascelia Pharma: A rocket roll out is the key to success PDF Report Presentation Webcast
Regulatory 2020-02-19 | First patient enrolled in pivotal Phase III clinical study SPARKLE with lead candidate Mangoral PDF Report Presentation Webcast
Regulatory 2020-02-14 | 2019 year-end financial report: Sites opened for recruitment to the pivotal Phase III study SPARKLE PDF Report Presentation Webcast
2020-02-11 | Ascelia Pharma wins the award for Best Life Science company in Malmö PDF Report Presentation Webcast
2020-01-13 | Five sites now opened in the pivotal Phase III clinical study SPARKLE for lead drug candidate Mangoral PDF Report Presentation Webcast
Regulatory 2019-12-18 | Nomination Committee appointed for AGM 2020 in Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2019-12-06 | Ascelia Pharma appoints Julie Waras Brogren as Chief Commercial Officer PDF Report Presentation Webcast
Regulatory 2019-11-14 | Bulletin from the Annual General Meeting in Ascelia Pharma AB on 14 November 2019 PDF Report Presentation Webcast
2019-11-08 | Preparations for Phase III study with Mangoral[®] on track PDF Report Presentation Webcast
Regulatory 2019-10-14 | Notice of Annual General Meeting of Ascelia Pharma AB PDF Report Presentation Webcast
Regulatory 2019-10-14 | Ascelia Pharma publishes Annual Report for the financial year 2018/2019 PDF Report Presentation Webcast
2019-09-11 | Ascelia Pharma to present at Redeye seminar in Malmö on 12 September 2019 PDF Report Presentation Webcast
2019-09-06 | Ascelia Pharma to present at Share Day (Aktiedagen) in Stockholm on 10 September 2019 PDF Report Presentation Webcast
